ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1931

Comprehensive Characterization of the Immune Infiltrate of Skin Biopsies from Cutaneous Lupus Erythematosus Patients Using Single Cell RNAseq

Agnes Gardet1, Thomas Carlile 1, Will Chou 1, Kejie Li 1, Alex Pellerin 1, Ravi Challa 1, Will Chen 1, Chao Sun 1, Nathalie Franchimont 2, Victoria Werth 3 and Dania Rabah 1, 1Biogen, Cambridge, 2Biogen, Cambridge, MA, 3Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA and Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cutaneous lupus erythematosus and single cell RNAseq, immunology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The immune infiltrate of skin lesions of Cutaneous Lupus Erythematosus (CLE) patients is known to be rich and complex. Single cell RNAseq (scRNAseq) is a unique approach to understand the cell-specific transcriptional heterogeneity in a complex tissue. ScRNAseq analyses of CLE skin biopsies has the unique potential to improve our understanding of human disease tissues and provide critical biological insights into the CLE pathogenesis.

Methods: Skin punch biopsies were obtained from healthy skin or lesional skin from CLE patients. Skin storage conditions and tissue dissociation protocol were optimized using healthy skin biopsies. RNAseq protocol was tested with blood-sorted pDCs and monocytes. Skin biopsies were collected from patients with DLE or SCLE. After tissue dissociation and cell staining, single CD45+ immune cells were sorted using flow cytometry and scRNAseq was performed using the SMART-seq2 protocol for cDNA synthesis and library preparation prior to sequencing.

Results: The scRNAseq protocol showed a similar sensitivity as a state-of-the-art published protocol (Villani AC et al, Science 2017). Avoiding cryopreservation and digestion of the skin biopsies with collagenase provided the best immune cell yield. Approximatively 85% of the isolated single cells produced RNAseq data that passed quality control. Analysis of 5 biopsies provided transcriptomic characterization of B-cells, CD4 and CD8 positive T-cells, Macrophages, Dendritic cells, and pDCs from skin lesions and suggested immune infiltrate heterogeneity in CLE patients. RNAseq data was also leveraged to define cell type marker panel for scqPCR which allowed a more focused cost- and time- effective approach for follow-up/validation of gene expression analyses.

Conclusion: We developed a protocol that successfully identified and characterized the immune infiltrate from skin punch biopsies of CLE patients. Analyses from additional patients will be needed to further understand the immunological heterogeneity of CLE skin lesions.


Disclosure: A. Gardet, Biogen, 1, 3; T. Carlile, Biogen, 1, 3; W. Chou, Biogen, 1, 3; K. Li, Biogen, 1, 3; A. Pellerin, Biogen, 1, 3; R. Challa, Biogen, 1, 3; W. Chen, Biogen, 1, 3; C. Sun, Biogen, 1, 3; N. Franchimont, Biogen, 1, 3; V. Werth, Biogen, 2, 5, Corbus Pharmaceuticals, 2, 9, University of Pennsylvania, 9; D. Rabah, Biogen, 1, 3.

To cite this abstract in AMA style:

Gardet A, Carlile T, Chou W, Li K, Pellerin A, Challa R, Chen W, Sun C, Franchimont N, Werth V, Rabah D. Comprehensive Characterization of the Immune Infiltrate of Skin Biopsies from Cutaneous Lupus Erythematosus Patients Using Single Cell RNAseq [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/comprehensive-characterization-of-the-immune-infiltrate-of-skin-biopsies-from-cutaneous-lupus-erythematosus-patients-using-single-cell-rnaseq/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comprehensive-characterization-of-the-immune-infiltrate-of-skin-biopsies-from-cutaneous-lupus-erythematosus-patients-using-single-cell-rnaseq/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology